AzTrials
AzTrials

Pelvic FractureNCT03195179

Primary Urethral Realignment Versus Suprapubic Cystostomy After Pelvic Fracture Urethral Injury

An observational study of Pelvic Fracture and Urethra Tear, run by University of Utah at 1 site in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Pelvic fracture urethral injuries (PFUI) occur in up to 10% of pelvic fractures. It remains controversial whether initial urethral realignment after PFUI decreases rates of urethral obstruction and the need for subsequent urethral procedures. Read more about this study

Who is it for?
Ages 18 years and older, men only
Conditions the study is for
Pelvic Fracture, Urethra Tear, Urethra Injury Male
How many people
200 participants
Where
1 siteUnited States
Study dates
1 Jan 2016to 31 Aug 2021
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • Men only
  • Adult, Older adult

Study population: Men experiencing a traumatic pelvic fracture urethral injury where there is a major urethral disruption that prevents passage of a catheter or a retrograde cystoscope.

Who may be able to join

  • Men > 18 years old Blunt force trauma Presence of pelvic fracture Urethral injury Inability to pass a Foley catheter retrograde through the injury into the bladder

Who cannot join

  • Straddle type urethral injuries without a pelvic fracture Passage of a catheter successfully in a retrograde fashion

Trial locations and contacts

1 site in 1 country.

United States1 site
  • University of Utah

    Salt Lake City, Utah, 84132

Other trials in United States

About this study

Official title: The Outcomes of Primary Urethral Realignment Versus Suprapubic Cystostomy After Pelvic Fracture Urethral Injury

Pelvic fracture urethral injuries (PFUI) occur in up to 10% of pelvic fractures. It remains controversial whether initial urethral realignment after PFUI decreases rates of urethral obstruction and the need for subsequent urethral procedures.

The retrospective record review should determine the utility of acute urethral realignment after PFUI.

Read the detailed description

A retrospective chart review to compare outcomes between urethral realignment (group 1) and suprapubic tube (SPT) placement (group 2). The comparison will be between two routinely practiced management approaches of urethral injury after pelvic fracture.

Prior studies demonstrate urethral realignment is associated with a 15% to 50% reduction in urethral obstruction, however, it has also been associated with higher rates of incontinence and erectile dysfunction. Our hypothesis is that early realignment of traumatic urethral injuries after pelvic fracture lowers the incidence of complications like urethral strictures and subsequent need for surgeries.

Keywords
pelvic fracture urethral injury, urethra, disruption, trauma
Medical subject headings
Hip Fractures, Wounds and Injuries

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

Study groups in NCT03195179
Study groupRoleWhat they receive
Suprapubic tube placementStandard of care management for men with complete urethral injuries where a Foley catheter fails to be placed will have a suprapubic tube placed to manage the acute urethral injury. This is a standard of care approach and a retrospective review will be done on the patient record to determine outcomes.
Urethral realignmentStandard of care management for men with complete urethral injuries where a Foley catheter fails to be placed will undergo urethral realignment with a combined antegrade / retrograde approach within 7 days of injury. This is a standard of care approach and a retrospective review will be done on the patient record to determine outcomes.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Urethral obstruction

    Rates of urethral obstruction identified by urethrogram or cystoscopy

    Measured: Through study completion, an average of 1 year

Secondary outcomes (14)
  1. Treatment rate for urethral obstruction

    The rate of interventions for urethral obstruction after injury

    Measured: Through study completion, an average of 1 year

  2. Urethroplasty complexity - gap length during urethroplasty

    The gap between the 2 severed ends of the urethra

    Measured: Through study completion, an average of 1 year

  3. Urethroplasty complexity - bulbar mobilization length during urethroplasty

    The length of bulbar mobilization

    Measured: Through study completion, an average of 1 year

  4. Urethroplasty complexity - corporal splitting during urethroplasty

    The need to split the 2 corporal bodies

    Measured: Through study completion, an average of 1 year

  5. Urethroplasty complexity - total obstruction of the urethra during urethroplasty

    Finding the urethra was completely obstructed

    Measured: Through study completion, an average of 1 year

  6. Urethroplasty complexity - urethral diverticulum discovered during urethroplasty

    Finding a urethral diverticulum

    Measured: Through study completion, an average of 1 year

  7. Urethroplasty complexity - urethral fistula present

    Finding a urethral fistula

    Measured: Through study completion, an average of 1 year

  8. Urethroplasty complexity - inferior pubectomy during urethroplasty

    The need to remove the inferior portion of the symphysis pubis

    Measured: Through study completion, an average of 1 year

  9. Urethroplasty complexity - total pubectomy during urethroplasty

    The need to remove the complete symphysis pubis

    Measured: Through study completion, an average of 1 year

  10. Erectile function- SHIM score

    Erectile function measured by the Sexual Health Inventory for Men (SHIM)

    Measured: Through study completion, an average of 1 year

  11. Erectile function - medical treatment rates

    Measured by the need for pharmacologic treatment of erectile dysfunction

    Measured: Through study completion, an average of 1 year

  12. Erectile function - surgical treatment rates

    Rates of surgical treatment of erectile dysfunction

    Measured: Through study completion, an average of 1 year

  13. Incontinence

    Rates of surgical treatment of incontinence

    Measured: Through study completion, an average of 1 year

  14. Post-injury complications

    Calvien-Dindo grading

    Measured: 3 month period post acute urethral injury

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted22 Jun 2017
  2. Study start1 Jan 2016
  3. Primary completion31 Aug 2021
  4. Study completion31 Aug 2021

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Retrospective
Enrolment
200 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03195179
Sponsor's protocol ID
00094160
Status last verified
Oct 2021
First submitted
16 Jun 2017
Last updated
27 Oct 2021
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

An observational study of Pelvic Fracture and Urethra Tear, run by University of Utah at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 27 Oct 2021. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Urethral obstruction (time frame: Through study completion, an average of 1 year). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 27 Oct 2021.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in